Sativex for spasticity due to MS launched in Spain

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

Sativex for spasticity due to MS launched in Spain

Postby MSUK » Mon Mar 14, 2011 12:00 am


Almirall, S.A. announces that Sativex® is now available to health professionals and patients in the Spanish hospital pharmacies. It is the first specific treatment for spasticity in MS patients who have not responded adequately to other treatments. Sativex® is administered as oromucosal spray enabling flexible dosage, which is particularly appropriate given the variable nature ofspasticity and MS itself.

Evidence from clinical trials shows that Sativex® has a positive impact on spasticity, sleep quality and mobility and enables patients to carry out everyday tasks such as getting up, getting dressed or washed. This affords patients greater independence and reduces the frequency of spasms. It is estimated that in Spain there are around 40,000 people with MS and up to 75% of them suffer from spasticity in the course of their disease.... Read More - ... ageid/1814
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm


Return to Sativex


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service